| Dr Khaled A Ahmed, MD | |
|
887 Hunts Point Ave, 1, Bronx, NY 10474-5412 | |
| (718) 576-2512 | |
| (718) 310-3313 |
| Full Name | Dr Khaled A Ahmed |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 26 Years |
| Location | 887 Hunts Point Ave, Bronx, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578881819 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 278003 (New York) | Secondary |
| 207X00000X | Orthopaedic Surgery | 278003 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hunts Points Medical Associates Office P.c. | 6709191802 | 2 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
GENova Biotherapeutics, Inc., ("GENova") - (OTCBB: GVBP.OB), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today named Aaron Whiteman as its Chief Executive Officer.
Creative arts therapies can improve anxiety, depression, pain symptoms and quality of life among cancer patients, although the effect was reduced during follow-up in a study by Timothy W. Puetz, Ph.D., M.P.H., of the National Institutes of Health, Bethesda, Md., and colleagues.
A research led by the Research Institute Vall d'Hebron (VHIR), in which the University of Valencia participated, has shown that pathological forms of the α-synuclein protein present in deceased patients with Parkinson's disease are able to initiate and spread in mice and primates the neurodegenerative process that typifies this disease.
› Verified 9 days ago
| Entity Name | Metropolitan Medical Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659626968 PECOS PAC ID: 2961650130 Enrollment ID: O20120912000683 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
GENova Biotherapeutics, Inc., ("GENova") - (OTCBB: GVBP.OB), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today named Aaron Whiteman as its Chief Executive Officer.
Creative arts therapies can improve anxiety, depression, pain symptoms and quality of life among cancer patients, although the effect was reduced during follow-up in a study by Timothy W. Puetz, Ph.D., M.P.H., of the National Institutes of Health, Bethesda, Md., and colleagues.
A research led by the Research Institute Vall d'Hebron (VHIR), in which the University of Valencia participated, has shown that pathological forms of the α-synuclein protein present in deceased patients with Parkinson's disease are able to initiate and spread in mice and primates the neurodegenerative process that typifies this disease.
› Verified 9 days ago
| Entity Name | Hunts Points Medical Associates Office P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174902787 PECOS PAC ID: 6709191802 Enrollment ID: O20150819007095 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
GENova Biotherapeutics, Inc., ("GENova") - (OTCBB: GVBP.OB), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today named Aaron Whiteman as its Chief Executive Officer.
Creative arts therapies can improve anxiety, depression, pain symptoms and quality of life among cancer patients, although the effect was reduced during follow-up in a study by Timothy W. Puetz, Ph.D., M.P.H., of the National Institutes of Health, Bethesda, Md., and colleagues.
A research led by the Research Institute Vall d'Hebron (VHIR), in which the University of Valencia participated, has shown that pathological forms of the α-synuclein protein present in deceased patients with Parkinson's disease are able to initiate and spread in mice and primates the neurodegenerative process that typifies this disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Khaled A Ahmed, MD 887 Hunts Point Ave, 1, Bronx, NY 10474-5412 Ph: (718) 576-2512 | Dr Khaled A Ahmed, MD 887 Hunts Point Ave, 1, Bronx, NY 10474-5412 Ph: (718) 576-2512 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
GENova Biotherapeutics, Inc., ("GENova") - (OTCBB: GVBP.OB), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today named Aaron Whiteman as its Chief Executive Officer.
Creative arts therapies can improve anxiety, depression, pain symptoms and quality of life among cancer patients, although the effect was reduced during follow-up in a study by Timothy W. Puetz, Ph.D., M.P.H., of the National Institutes of Health, Bethesda, Md., and colleagues.
A research led by the Research Institute Vall d'Hebron (VHIR), in which the University of Valencia participated, has shown that pathological forms of the α-synuclein protein present in deceased patients with Parkinson's disease are able to initiate and spread in mice and primates the neurodegenerative process that typifies this disease.
› Verified 9 days ago
Jeffrey Bruce Knox, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 199 Mount Eden Pkwy Fl 4, Bronx, NY 10457 Phone: 718-590-1800 | |
Paul Kleinman, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2016 Bronxdale Ave, Bronx, NY 10462 Phone: 718-863-8695 Fax: 718-863-5147 | |
Dr. Eial Faierman, MD Orthopedic Surgery Medicare: May Accept Medicare Assignments Practice Location: 3612 East Tremont Avenue, Bronx, NY 10465 Phone: 718-409-9494 Fax: 718-824-8026 | |
Dr. Vanessa Charubhumi, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-4321 | |
Dr. David M.s. Shein, M.D. Orthopedic Surgery Medicare: May Accept Medicare Assignments Practice Location: 1250 Waters Pl, Suite 903, Bronx, NY 10461 Phone: 718-450-9955 Fax: 718-450-9988 | |
Dr. Shai Shemesh, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2600 Netherland Ave, Apt 925, Bronx, NY 10463 Phone: 646-647-5973 | |
Paul E Levin, MD Orthopedic Surgery Medicare: May Accept Medicare Assignments Practice Location: Mmc - Dept. Of Orthopedic Surg, 3400 Bainbridge Avenue, 6th Fl, Bronx, NY 10467 Phone: 718-920-2060 |